Quintín Rascón-Cruz (Q Rascón-Cruz)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Breast Cancer Cells

Acute Lymphoblastic Leukemia

Recombinant Human

Risk Assessment

Top Venues

Apoptosis : an international journal on programmed cell death

Biotechnology letters

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

A J Sardiña-Peña, L Ballinas-Casarrubias, T S Siqueiros-Cendón, E A Espinoza-Sánchez, N R Flores-Holguín, B F Iglesias-Figueroa, Quintín Rascón-Cruz
Thermostability improvement of sucrose isomerase PalI NX-5: a comprehensive strategy. Biotechnology letters (2023)
Blanca Flor Iglesias-Figueroa, Tania S Siqueiros-Cendón, Denisse A Gutiérrez, Renato J Aguilera, Edward Alexander Espinoza-Sánchez, Sigifredo Arévalo-Gallegos, Armando Varela-Ramirez, Quintín Rascón-Cruz
Recombinant human lactoferrin induces apoptosis, disruption of F-actin structure and cell cycle arrest with selective cytotoxicity on human triple negative breast cancer cells. Apoptosis : an international journal on programmed cell death 24 (7-8) (2020)
Sayuri Nakamura-Bencomo, Denisse A Gutiérrez, Elisa Robles-Escajeda, Blanca Flor Iglesias-Figueroa, Tania S Siqueiros-Cendón, Edward Alexander Espinoza-Sánchez, Sigifredo Arévalo-Gallegos, Renato J Aguilera, Quintín Rascón-Cruz, Armando Varela-Ramirez
Recombinant human lactoferrin carrying humanized glycosylation exhibits antileukemia selective cytotoxicity, microfilament disruption, cell cycle arrest, and apoptosis activities. Investigational new drugs 39 (2) (2020)